• Institute of Biomedical Engineering, West China School of Basic Medical Science & Forensic Medicine, Sichuan University, Chengdu 610041, P.R.China;
Export PDF Favorites Scan Get Citation

Postmenopausal osteoporosis is a type of osteoporosis with high bone transformation rate, caused by a decrease of estrogen in the body, which is a systemic bone disease characterized by decreased bone mass and increased risk of fracture. In recent years, as a kind of non-pharmacologic treatment of osteoporosis, defined by whole-body vibration less than 1 g (g = 9.81 m/s2), low magnitude whole-body vibration is widely concerned, mainly because of its small side effects, simple operation and relative safety. Studies have shown that low magnitude whole-body vibration can improve bone strength, bone volume and bone density. But a lot of research found that, the therapeutic effects of low magnitude whole-body vibration are different depending on ages and hormone levels of subjects for animal models or human patients. There has been no definite vibration therapy can be applied to each subject so far. Studies of whole-body and cellular level suggest that low magnitude whole-body vibration stimulation is likely to be associated with changes of hormone levels and directed differentiation of stem cells. Based on the analysis of related literature in recent years, this paper made a review from vibration parameters, vibration effects and the mechanisms, to provide scientific basis and clinical guidance for the treatment of postmenopausal osteoporosis with low magnitude whole-body vibration.

Citation: LI Huiming, LI Liang. Low magnitude whole-body vibration and postmenopausal osteoporosis. Journal of Biomedical Engineering, 2018, 35(2): 301-306. doi: 10.7507/1001-5515.201801071 Copy

  • Previous Article

    Design of longitudinal auto-tracking of the detector on X-ray in digital radiography
  • Next Article

    Endothelial injury and its repair strategies after intravascular stents implantation